Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 10;14(1):956.
doi: 10.1038/s41598-023-50332-9.

Breaking barriers in Candida spp. detection with Electronic Noses and artificial intelligence

Affiliations

Breaking barriers in Candida spp. detection with Electronic Noses and artificial intelligence

Michael L Bastos et al. Sci Rep. .

Abstract

The timely and accurate diagnosis of candidemia, a severe bloodstream infection caused by Candida spp., remains challenging in clinical practice. Blood culture, the current gold standard technique, suffers from lengthy turnaround times and limited sensitivity. To address these limitations, we propose a novel approach utilizing an Electronic Nose (E-nose) combined with Time Series-based classification techniques to analyze and identify Candida spp. rapidly, using culture species of C. albicans, C.kodamaea ohmeri, C. glabrara, C. haemulonii, C. parapsilosis and C. krusei as control samples. This innovative method not only enhances diagnostic accuracy and reduces decision time for healthcare professionals in selecting appropriate treatments but also offers the potential for expanded usage and cost reduction due to the E-nose's low production costs. Our proof-of-concept experimental results, carried out with culture samples, demonstrate promising outcomes, with the Inception Time classifier achieving an impressive average accuracy of 97.46% during the test phase. This paper presents a groundbreaking advancement in the field, empowering medical practitioners with an efficient and reliable tool for early and precise identification of candidemia, ultimately leading to improved patient outcomes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Correlation graph of the results of applying the Nemenyi post-hoc test on the set of results for each model. In this type of graph, when it is farther from 1, the elements are more divergent; that is, they are statistically different.
Figure 2
Figure 2
Flow for sample identification and classification. First, control samples derived from the ATCC company are used to analyze and define the mycological diagnosis by the Laboratory of Medical Mycology. With this, the already cultivated species are identified and separated in Petri dishes. These cultures are then placed in the E-nose to identify the VOCs. With the collected data, pre-processing routines are executed to use the data already treated by the AI models. At the end, a species identification report is generated.
Figure 3
Figure 3
(a): Electronic Nose device used in experiments: (1) The Electronic Nose is packaged in a compact box; (2) The on-off switch activates it; (3) All connections are made of PTFE; (4) It has activated carbon filter and (5) PTFE filter; (6) Sample chamber also made of PTFE. (b): Example of samples of Candida albicans (URM8368) used to create the database. All were cultivated in Petri dishes using Sabouraud Dextrose agar culture medium. (c):E-Nose collection cycle. (1) Camera suction step (2) Sensor stabilization step (3) Camera cleaning (purge). (d): Data from the readings of each sensor over time for the samples of C. albicans. (e): Data readings from C. krusei after one day of culture. (f): Data readings from C. krusei after two days of culture.
Figure 4
Figure 4
Two dimensions from Principal Component Analysis (a) and Uniform Manifold Approximation and Projection for Dimension Reduction (b).

Similar articles

Cited by

  • First Step on the Way to Identify Dermatophytes Using Odour Fingerprints.
    Machová L, Gaida M, Semerád J, Kolařík M, Švarcová M, Jašica A, Grasserová A, Awokunle Hollá S, Hubka V, Stefanuto PH, Cajthaml T, Focant JF, Wennrich A. Machová L, et al. Mycopathologia. 2025 Jan 7;190(1):10. doi: 10.1007/s11046-024-00905-7. Mycopathologia. 2025. PMID: 39775995 Free PMC article.
  • Rapid Molecular Diagnostics in Vulvovaginal Candidosis.
    Akinosoglou K, Schinas G, Papageorgiou D, Polyzou E, Massie Z, Ozcelik S, Donders F, Donders G. Akinosoglou K, et al. Diagnostics (Basel). 2024 Oct 17;14(20):2313. doi: 10.3390/diagnostics14202313. Diagnostics (Basel). 2024. PMID: 39451635 Free PMC article. Review.

References

    1. Garbee DD, Pierce SS, Manning J. Opportunistic fungal infections in critical care units. Crit. Care Nurs. Clin. N. Am. 2017;29(1):67–79. doi: 10.1016/j.cnc.2016.09.011. - DOI - PubMed
    1. Li F, Zhou M, Zou Z, Li W, Huang C, He Z. A risk prediction model for invasive fungal disease in critically ill patients in the intensive care unit. Asian Nurs. Res. (Korean Soc. Nurs. Sci.) 2018;12(4):299–303. doi: 10.1016/j.anr.2018.11.004. - DOI - PubMed
    1. Matthaiou DK, Christodoulopoulou T, Dimopoulos G. How to treat fungal infections in icu patients. BMC Infect. Dis. 2015;15(1):1–8. doi: 10.1186/s12879-015-0934-8. - DOI - PMC - PubMed
    1. Pietro P. Performance of Candida albicans germ tube antibodies (cagta) and its association with (1 3)-β-d-glucan (bdg) for diagnosis daof invasive candidiasis (ic) Diagn. Microbiol. Infect. Dis. 2019;93(1):39–43. doi: 10.1016/j.diagmicrobio.2018.07.007. - DOI - PubMed
    1. Clancy, P. G. P. C. K. D. A. C. & Marr, K. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of america. Clin. Infect. Dis.62, 1–50 (2016). - PMC - PubMed

Supplementary concepts